| ||
| Grace to buy Synthetech for chiral expertise In-PharmaTechnologist.com The deal, worth around $19m, will add chiral chemistry and peptide intermediate synthesis units to Grace's pharmaceutical chemistry offering and present a ... See all stories on this topic » |
Tip: Use a plus sign (+) to match a term in your query exactly as is. Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment